Very early researchStudy completedNCT03463408What this trial is testingImmunotherapy + Radiation in Resectable Soft Tissue SarcomaWho this might be right forSarcoma University of Rochester 14
Not applicableEnded earlyNCT00253552What this trial is testingG-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic DisordersWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more OHSU Knight Cancer Institute 4
Early research (Phase 1)Study completedNCT00002138What this trial is testingA Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days.Who this might be right forSarcoma, KaposiHIV Infections Daiichi Pharmaceuticals
Testing effectiveness (Phase 2)UnknownNCT05602415What this trial is testingAnlotinib and Radiotherapy in Resectable Soft Tissue SarcomaWho this might be right forSoft Tissue SarcomaHigh Risk of RecurrenceAnlotinib+1 more Ruijin Hospital 41
Testing effectiveness (Phase 2)Study completedNCT02799485What this trial is testingSEphB4-HSA in Treating Patients With Kaposi SarcomaWho this might be right forSkin Kaposi Sarcoma AIDS Malignancy Consortium 23
Early research (Phase 1)Looking for participantsNCT06340204What this trial is testingWeekly Irinotecan Liposomes in Recurrent or Refractory Ewing SarcomaWho this might be right forEwing Sarcoma Peking University People's Hospital 44
Testing effectiveness (Phase 2)Study completedNCT00003335What this trial is testingUmbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Case Comprehensive Cancer Center 44
Testing effectiveness (Phase 2)Looking for participantsNCT06114225What this trial is testingPulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical TrialWho this might be right forOsteosarcoma Ruijin Hospital 43
Testing effectiveness (Phase 2)Study completedNCT01524848What this trial is testingPazopanib in Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and SunitinibWho this might be right forGastrointestinal Stromal Tumors Scandinavian Sarcoma Group 72
Testing effectiveness (Phase 2)WithdrawnNCT02011126What this trial is testingImetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid TumorsWho this might be right forHepatoblastomaPreviously Treated Childhood RhabdomyosarcomaRecurrent Childhood Liver Cancer+5 more Children's Oncology Group
Early research (Phase 1)UnknownNCT02013336What this trial is testingPhase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid TumorsWho this might be right forRecurrent or Refractory Solid TumorsEwing SarcomaRhabdomyosarcoma+2 more South Plains Oncology Consortium 30
Not applicableUnknownNCT04158414What this trial is testingApplying PET/MR in Oncology - a Prospective ProjectWho this might be right forLymphomaNasopharyngeal CancerEsophageal Cancer+5 more Tel-Aviv Sourasky Medical Center 500
Early research (Phase 1)Study completedNCT01005797What this trial is testingStudy of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung CancersWho this might be right forRenal CancerNon Small Cell Lung Cancer (NSCLC)Soft Tissue Sarcoma Medical University of South Carolina 38
Not applicableStudy completedNCT01764789What this trial is testingStress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast CancerWho this might be right forAnxiety DisorderDepressionFatigue+17 more Ohio State University Comprehensive Cancer Center 39
Early research (Phase 1)Study completedNCT00889408What this trial is testingDT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or LymphomaWho this might be right forLeukemiaLymphoma Masonic Cancer Center, University of Minnesota 25
Early research (Phase 1)Study completedNCT03150810What this trial is testingStudy to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid Tumors BeiGene 139
Very early researchLooking for participantsNCT07048249What this trial is testingSingle Arm Romiplostim to Prevent CITWho this might be right forEwings SarcomaChemotherapy Induced Thrombocytopenia Children's Hospital Medical Center, Cincinnati 26
Large-scale testing (Phase 3)Study completedNCT02818725What this trial is testingI-MVAC +/- Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma Without H-Ras Nor K-Ras MutationsWho this might be right forInfiltrating Urothelial CarcinomaKRAS Gene Mutation UNICANCER 133
Early research (Phase 1)Study completedNCT03085225What this trial is testingTrabectedin Combined With Durvalumab in Patients With Advanced Pretreated Soft-tissue Sarcomas and Ovarian Carcinomas.Who this might be right forOvarian CarcinomaSoft Tissue Sarcoma Institut Bergonié 40
Testing effectiveness (Phase 2)Study completedNCT02428192What this trial is testingNivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine LeiomyosarcomaWho this might be right forMetastatic LeiomyosarcomaUnresectable LeiomyosarcomaUterine Corpus Leiomyosarcoma National Cancer Institute (NCI) 20